The cancer mortality rate continued to decline but increases in cancer in young people, women and populations of color are concerning.

Progress is lagging against pancreatic cancer, which is the third-leading cause of U.S. cancer deaths. New cases and deaths ...

The addition of radiation to chemotherapy did not improve overall survival in patients with locally advanced endometrial ...

GSK (GSK) has received expanded approval from the European Commission for its drug Jemperli, also known as dostarlimab, in the treatment of endometrial cancer. Read more here.

Though the 5-year relative survival rate for most cancers have improved in the past 40 years, uterine and cervical cancer survival rates have declined. Uterine cancer actually has a lower survival ...

Getty Deaths from uterine cancer are also on the rise, as the study says it’s “one of the few cancers with increasing mortality; from 2013 to 2022 the death rate rose by 1.5% per year.” ...

In Arizona, lung cancer screening rates remain very low. One Banner doctor is trying to spread awareness on screenings to improve early detection.

Death rates for Black people with prostate, stomach, and uterine cancer are twice as high as for white Americans. Cancer cases rising in young people The report does contain some good news ...